A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
To identify plasma markers predictive of therapeutic response in patients with multidrug resistant tuberculosis (MDR-TB).Fifty HIV-negative patients with active pulmonary MDR-TB were analysed for six soluble analytes in plasma at the time of initiating treatment (baseline) and over six months therea...
Main Authors: | Selena Ferrian, Claudia Manca, Sugnet Lubbe, Francesca Conradie, Nazir Ismail, Gilla Kaplan, Clive M Gray, Dorothy Fallows |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5413057?pdf=render |
Similar Items
-
Frequency of Circulating CD4+Ki67+HLA-DR− T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion
by: Selena Ferrian, et al.
Published: (2018-10-01) -
Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.
by: Claudia Manca, et al.
Published: (2013-01-01) -
A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.
by: Halima M Said, et al.
Published: (2016-01-01) -
Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.
by: Catherine Riou, et al.
Published: (2012-01-01) -
A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion.
by: Catherine Riou, et al.
Published: (2014-01-01)